DOXORUBICIN INDUCED CARDIOMYOPATHY

Clinical trials for DOXORUBICIN INDUCED CARDIOMYOPATHY explained in plain language.

Never miss a new study

Get alerted when new DOXORUBICIN INDUCED CARDIOMYOPATHY trials appear

Sign up with your email to follow new studies for DOXORUBICIN INDUCED CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a common pill shield hearts from Chemo's harsh side effects?

Disease control Not yet recruiting

This study is testing if a blood pressure medication called telmisartan can protect the heart from damage caused by a powerful chemotherapy drug (doxorubicin) used to treat breast cancer. It will involve 36 women with breast cancer who are about to start this specific chemotherap…

Matched conditions: DOXORUBICIN INDUCED CARDIOMYOPATHY

Phase: PHASE1, PHASE2 • Sponsor: Tanta University • Aim: Disease control

Last updated Mar 18, 2026 14:42 UTC

DOXORUBICIN INDUCED CARDIOMYOPATHY

Get alerted when new DOXORUBICIN INDUCED CARDIOMYOPATHY trials appear

Can a common pill shield hearts from Chemo's harsh side effects?